The global C-arms market size was worth USD 2,003 million in 2021. It is expected to reach USD 3,016 million by 2030, growing at a CAGR of 5.25% during the forecast period (2022–2030).
Imaging techniques are becoming a need that can be found in practically all hospitals with adequate equipment. For intraoperative imaging, surgeons, orthopedic surgeons, traumatologists, vascular surgeons, and cardiologists employ C-arms. A C-arm machine identifies itself as an advanced medical imaging device operating on X-ray technology's core premise. A C-Arm device is a sophisticated X-ray-based medical imaging instrument. They are mainly utilized for their fluoroscopy skills, though they also have radiography capabilities. The C-Arm is so named because of its C-shaped arm, which transmits the x-ray source to the detector. The type of C-Arm selected depends on the procedures to be performed. C-Arm selection requires complete clarity regarding its intended use.
Numerous market participants make continuous efforts to develop advanced systems, such as the incorporation of Artificial Intelligence (AI)-enabled advancements and 3D mapping functionality in a C-arm system that will strengthen process planning, increase real-time intraoperative guidance, and significantly decrease surgical operation times. The primary factors driving the market's expansion are the increasing elderly population, the prevalence of chronic diseases, advances in mobility and imaging abilities, and the demand for imaging technologies in emerging nations. In addition, C-arms are now utilized in various medical fields, and their uses are anticipated to expand. The market for C-arms is driven by these reasons and the rising demand for a healthcare system in developing nations.
The increasing senior population and the burden of chronic diseases are two of the primary drivers driving the expansion of the C-arm market; as the percentage of elderly patients increases, so does the number of surgical procedures. According to a World Health Organization report, cancer became the second biggest cause of death worldwide, with an estimated 9.6 million deaths and 18.1 million new cases in 2018. According to the American Cancer Society, in 2020, there were approximately 1,806,590 new cancer cases and 606,520 cancer deaths across the United States alone. This propelled the market, as C-arm machines are used as intraoperative imaging devices for cancer, orthopedics, cardiology, neurology, etc., surgeries.
Additionally, according to a study report in the Journal of the American College of Cardiology, 2020, there were 523 million persons with cardiovascular disease in 2019 as opposed to 271 million in 1990. CVD deaths have risen from 12.1 million in 1990 to 18.6 million in 2019. As C-arms are utilized for intraoperative imaging during surgical procedures, the increase in cardiovascular disorders will stimulate the market. As chronic diseases are more prevalent among the elderly, aging is a contributing cause to their increasing prevalence.
In coming years, there are expected to be 727 million people worldwide who are 65 or older, estimates the Population Division of the UN Department of Economic and Social Affairs. The number of senior citizens worldwide is predicted to double in the coming three decades, surpassing over 1.5 billion in 2050. Chronic diseases are becoming more common as the population ages, aiding the market's expansion. As a result, the market for C-arms is anticipated to expand throughout the forecast period, especially in light of factors like the growing elderly population and the burden of chronic diseases.
The healthcare infrastructure in developed countries like the United States, Canada, and Germany is robust. In contrast, developing countries struggle to have a better healthcare infrastructure as medical treatment costs rise yearly. Additionally, modern technology is required for better healthcare facilities, which is again a market constraint due to the high cost of the equipment. These two elements will prevent the market from expanding. For instance, one of the most lethal diseases, cancer, requires prompt treatment, but the market is constrained by the high cost of surgeries and equipment.
Furthermore, adaptable C-arms are typically expensive, as implied by their advanced components and features. This demonstrates why small businesses and new entrants can't make the necessary effort to purchase these C-arm imaging devices. Thus, restricting the C-arms market from expanding.
Over the forecast period, the increase in public-private funding for targeted research activities, the popularization of personalized medicine, and the rise in product innovations and development due to global technological advancements will create lucrative opportunities for market participants. Additionally, the growing number of strategic alliances, the rising rate of internet penetration, the growing number of hospitals and laboratories, the increasing demand for minimally invasive surgical operations in developing regions, and the rising per capita healthcare spending will all contribute to the market's future growth.
Developing new implementations for C-Arms devices will also bolster its market growth in the future. C-Arms are used in intraoperative 3D, minimally invasive surgery, hybrid operating rooms, interventional angiography, radiology, cardiology, surgical navigation, orthopedics, neurology, gallbladder, liver, and bone imaging, diagnostic testing, kidney drainage, percutaneous valve replacements, abdominal and thoracic aortic aneurysm repair, cardiac surgery, vascular surgery, gastroenterology, and neurostimulation. New devices such as FL C-Arm, Philips c-arm, GE c-arm, and Siemens c-arm are utilized for this aim. Thus, product development will result in more market opportunities.
| Study Period | 2018-2030 | CAGR | 5.25% |
| Historical Period | 2018-2020 | Forecast Period | 2022-2030 |
| Base Year | 2021 | Base Year Market Size | USD 2,003 Million |
| Forecast Year | 2030 | Forecast Year Market Size | USD 3016 Million |
| Largest Market | North America | Fastest Growing Market | Europe |
The global C-arms market is analyzed across North America, Asia-Pacific, Europe, South America, and the Middle East and Africa.
North America will command the largest market share, expanding at a CAGR of 4.85% during the forecast period. A fair reimbursement system, rising adoption of cutting-edge technologies, an upgraded healthcare infrastructure, and consumers with significant purchasing power all contribute to the market's growth. The Centers for Medicare and Medicaid Services reported that the United States spent nearly USD 4.1 trillion on healthcare in 2020 or almost 19.7% of the country's total GDP. Additionally, it is anticipated that the region's demand for C-arm equipment will expand because of elective surgery rates following the pandemic and the rising frequency of chronic diseases.
The region's high standards for healthcare infrastructure, the aging society, an increase in the frequency of chronic illnesses, and frequent medical testing are additional factors projected to promote market expansion. According to a study that appeared in ACR Open Rheumatology under the heading "The Relation of the Chronic Disease Epidemic to the Health Care Crisis," in 2020, roughly 50% of the US population was affected by a chronic disease, and chronic diseases were responsible for 86 % of health care spending. Nearly 836,546 people in the United States passed away in 2018, as reported by the American Heart Association, as a result of cardiovascular disorders. As a result, more surgeries are performed due to chronic illnesses, which raises the demand for imaging equipment like C-arms.
Europe will expand at a CAGR of 4.78, accounting for USD 812 million by 2030. The European medical system provides access to cutting-edge advanced technologies for patients and is a lucrative market for most diagnostic companies. The demand for C-arms is influenced by the rise in chronic illnesses, aging populations, and technological advancements. Out of 83.1 million inhabitants in Germany, 16.2 million were above 67 years old, according to the Germany Federal Statistical Office's 2020 report. By 2040, this proportion is projected to increase to 21.4 million. The need for C-arms devices is fueled by the growing geriatric population, which makes these populations more susceptible to orthopedic, cardiovascular, and neurological conditions that call for surgery.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global C-arms market is segmented into type, application, and region.
Type-wise, the global C-arms market is categorized into Fixed C-arms and Mobile C-arms.
The Mobile C-arms section is projected to advance at a CAGR of 5.51% and hold the largest market share over the forecast period. Based on X-ray technology, a mobile C-arm is a flexible medical imaging tool that can be utilized in different operating rooms (ORs) throughout a clinic. The device's name comes from the C-shaped arm that joins the X-ray source and detector. The segment is anticipated to have considerable growth over the forecast period due to technical developments in the region and the introduction of new mobile C-arm platforms. For instance, Royal Philips introduced the Philips Zenition mobile C-arm platform to improve operating room performance and workflow efficiency in February 2019.
The Fixed C-arms section will hold the second-largest market share. The fixed C-arm is a stationary imaging technology typically installed in a designated space, known as Cath labs. Compared to mobile C-arms, they usually occupy a more prominent position in the space. Aside from angiography, therapeutics, and orthopedic treatments, cardiology procedures are the primary uses of fixed C-arms. The market for fixed C-arm devices is anticipated to rise along with the incidence of chronic diseases in the world, fueling the expansion of this market. Companies are constantly inventing new technologies and refining their already existing ones. They are also involved in other business expansion initiatives, including mergers, acquisitions, and strategic alliances, which are expected to support the expansion of the fixed C-arm market sector.
The global C-arms market is categorized into Cardiology, Gastroenterology, Neurology, Orthopedics & Trauma, Oncology, and Other Applications.
The Cardiology section is projected to advance at a CAGR of 5.5% and hold the largest market share over the forecast period. C-arm imaging devices are crucial to effectively managing several cardiovascular disorders, including atherosclerosis, ischemic-reperfusion injury, and other microvascular diseases, including hypertension. The main factor fueling the segment's rise is an upsurge in cardiovascular disease (CVD) occurrences worldwide. For instance, according to the WHO 2021 report, cardiovascular illnesses remain the most significant cause of mortality worldwide. In 2019, 17.9 million people died from cardiovascular diseases or nearly 32 % of all deaths. Cardiology treatments for cardiac imaging utilize imaging systems built on C-arm platforms. They can create 3D images of the cardiac anatomy, which is particularly helpful during cardiac surgeries.
The Orthopedics & Trauma section is projected to have the second-largest market share. Due to the rising prevalence of orthopedic illnesses, the increasing number of severe trauma cases, and technological developments in the goods, the orthopedics and trauma segment of the C-arms market is anticipated to increase throughout the projected period. Nowadays, trauma and orthopedic operations require C-arm fluoroscopy as a vital tool. A crucial reason driving the segment's growth is that it enhances the surgeon's technical proficiency and, as a result, lowers the patients' morbidity and duration of hospital stay.
Covid-19 had some profound adverse impacts on the global advanced ceramics market.
COVID-19 spread across the world from China, making the whole world stand still and to a complete lockdown situation. Covid-19 is an infectious disease that was caused by a newly discovered coronavirus. During the time, the fatality rate among the population above 40 was also high globally. The disease causes severe illness for people suffering from medical conditions like diabetes, cardiovascular disease, chronic respiratory disease, etc.
Considering the situation during that time, it was declared a pandemic which led to numerous countries, including the major economies like China, the United States, India, and others, implementing lockdowns which adversely affected the global economy.
In the first two quarters of 2020, the economic and industrial operations temporarily halted. Almost every manufacturing unit where advanced ceramics is used, such as electrical and electronics, transportation, industrial, chemical, and other End-user Industries (except medical), reduced their manufacturing capacities due to the lack of workers. The lockdown implemented put a halt to global supply chains. This resulted in repercussions in terms of both production and demand for advanced ceramics.
With time the lockdowns were uplifted, and relaxation was made to the public. Gradually, the economy picked up the pace and started its operations, bringing the demand in the global advanced ceramics market and increasing among various industries. As the situation improved during the initial months of 2021, the economies also strengthened their fiscal policies and initiated their development process; the end-user industries began their activities, bringing the overall ceramics market back on track.
